Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Current Taxes (2023 - 2025)

Zenas BioPharma has reported Current Taxes over the past 3 years, most recently at $118000.0 for Q4 2025.

  • Quarterly results put Current Taxes at $118000.0 for Q4 2025, down 44.08% from a year ago — trailing twelve months through Dec 2025 was $118000.0 (down 44.08% YoY), and the annual figure for FY2025 was $118000.0, down 44.08%.
  • Current Taxes for Q4 2025 was $118000.0 at Zenas BioPharma, up from $5000.0 in the prior quarter.
  • Over the last five years, Current Taxes for ZBIO hit a ceiling of $301000.0 in Q4 2023 and a floor of $5000.0 in Q1 2025.
  • Median Current Taxes over the past 3 years was $164500.0 (2024), compared with a mean of $158750.0.
  • Biggest five-year swings in Current Taxes: fell 29.9% in 2024 and later tumbled 44.08% in 2025.
  • Zenas BioPharma's Current Taxes stood at $301000.0 in 2023, then decreased by 29.9% to $211000.0 in 2024, then tumbled by 44.08% to $118000.0 in 2025.
  • The last three reported values for Current Taxes were $118000.0 (Q4 2025), $5000.0 (Q1 2025), and $211000.0 (Q4 2024) per Business Quant data.